Growing thyroid nodules with benign histology and RET rearrangement.
Some benign thyroid nodules are stationary in size over time while others grow progressively, indicating that there is a broad individual variability within benign nodules. To date, it is very difficult to predict if a benign thyroid nodule will grow in size and which will be its trend over time. While BRAF(V600E) is a highly specific marker of thyroid cancer, RET rearrangements have been disclosed also in non malignant thyroid lesions and their biological significance is debated. We compared the clinical history of three histologically benign thyroid nodules harboring RET rearrangements with that of 6 benign nodules bearing wild type RET. The nodules negative for RET rearrangements were followed for 10 years by ultrasonographic evaluation, showing a slow, constant enlargement. Three patients with benign nodules diagnosed at FNAC, were followed for 11, 9 and 7 years by annual ultrasonographic evaluation. After several years of latency, the nodules had an unexpected and gradual increase in their dimensions, reaching a large final size. A second FNAC confirmed the previous cytologic diagnosis of benign lesion. Because of the increasing size of the nodules, the patients were advised to surgery. Before undergoing thyroidectomy, we performed molecular diagnostic tests that revealed the absence of BRAF(V600E) and the presence of RET/PTC-1 in one nodule and RET/PTC-3 in the two others. Despite the presence of this oncogene, the samples were histologically classified as benign hyperplastic nodules. These findings lead us to speculate that histologically benign hyperplastic thyroid nodules containing RET rearrangements might represent a subgroup of nodules with a rapid size increase.
Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università Federico II, Napoli, Italy.
Vincenzo
V
Marotta
Anna
A
Guerra
Maria Rosaria
MR
Sapio
Elisabetta
E
Campanile
Manuela
M
Motta
Gianfranco
G
Fenzi
Guido
G
Rossi
Mario
M
Vitale
D000328:Adult; D000368:Aged; D044963:Biopsy, Fine-Needle; D005260:Female; D015321:Gene Rearrangement; D005819:Genetic Markers; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000235:genetics; D016606:Thyroid Nodule / Q000000981:diagnostic imaging / Q000235:genetics* / Q000473:pathology*; D013965:Thyroidectomy; D014463:Ultrasonography
D005819:Genetic Markers; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human